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Hereditary haemochromatosis (HH) is a common iron overload
disorder caused by mutations in HFE or TFR2, which impair the
liver iron regulatory hormone, hepcidin (Hamp). This study
aimed to examine the effects of disruption of Hfe and Tfr2 on
liver iron loading and injury in mouse models of HH. Methods:
Iron status was determined in single mutant (Hfe-/- and
Tfr2Y245X) and double mutant (Hfe-/-xTfr2Y245X) mice (10-14
weeks of age) by measuring plasma and liver iron concentra-
tion. Hamp expression was measured by real-time PCR. Liver
injury was evaluated by measuring serum alanine transami-
nase (ALT) activity, hepatic histology, collagen deposition (Sirius
red) and iron levels (Perls). Hepatic oxidative stress was deter-
mined by measuring F2-isoprostane, a marker of lipid peroxi-
dation, by gas chromatography-mass spectrometry and
anti-oxidant enzyme, superoxide dismutase (SOD). Results: Hfe-
/-xTfr2Y245X mice had significantly elevated hepatic iron levels
(1.5-fold; P<0.01) with a periportal iron distribution, increased
plasma iron (1.7-fold; P<0.01) and transferrin saturation (1.3-
fold; P<0.01) compared with Hfe-/- and Tfr2Y245X mice, which
in turn, were increased compared with wild-type mice. Hamp
was significantly reduced in Hfe-/- and Tfr2Y245X mice to 30%
(P<0.01) and in Hfe-/-xTfr2Y245X mice to 1% (P<0.01) com-
pared with wild-type mice. Hfe-/-xTfr2Y245X mice had elevated
serum ALT activity (2 fold; P<0.001) compared with the other
types of mice. Hfe-/-xTfr2Y245X mice had scattered lobular
aggregates of mononuclear inflammatory cells, steatosis and
increased portal tract collagen deposition. By contrast, Hfe-/-
and Tfr2Y245X mice showed minimal hepatic inflammation, with
no increased collagen deposition in Tfr2Y245X mice. F2-iso-
prostane levels were significantly elevated in Hfe-/-xTfr2Y245X
(4.2-fold; P<0.001), Tfr2Y245X mice (3.2-fold; P<0.001) and
Hfe-/- mice (2.0-fold; P<0.01) and SOD was increased in Hfe-/-
xTfr2Y245X (1.5-fold; P<0.05) compared with wild-type mice.
Conclusion: The disruption of Hfe or Tfr2 causes hepatic iron
loading and lipid peroxidation. However, the disruption of both
Hfe and Tfr2 produces more severe hepatic iron overload and
lipid peroxidation, with inflammation, portal fibrosis and steato-
sis. Hfe-/-xTfr2Y245X mice provide a novel model of iron-induced
liver injury.
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